Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C19 | P33261 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | GLA | P06280 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18217824 | 0.89 | CA12 (0.35) | CYP2C19MEN1KMT2ACYP1A2 | |
| SCHEMBL18533398 | 0.82 | — | — | |
| SCHEMBL32678614 | 0.82 | CA12 (0.46) | CYP2C19MEN1KMT2ACYP1A2TSHR | |
| SCHEMBL763790 | 0.79 | KIF11 (0.37) | — | |
| SCHEMBL32678619 | 0.77 | CA12 (0.50) | CYP2C19MEN1KMT2ACYP1A2TSHR | |
| SCHEMBL32678616 | 0.77 | CA12 (0.50) | CYP2C19MEN1KMT2ACYP1A2TSHR | |
| SCHEMBL32678618 | 0.77 | CA12 (0.50) | CYP2C19MEN1KMT2ACYP1A2TSHR | |
| Ammonia Solution, Strong SCHEMBL735815 | 0.77 | KIF11 (0.36) | — | |
| Hydrochloric Acid SCHEMBL20637046 | 0.77 | KIF11 (0.36) | — | |
| SCHEMBL32678355 | 0.76 | LOX (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8137700-B2 | Main chain acid-degradable polymers for the delivery of bioactive materials | U.S. DEPARTMENT OF ENERGY (US) | 2012-03-20 | — | — | US | disclosed |
| US-20090220615-A1 | Main Chain Acid-Degradable Polymers for the Delivery of Bioactive Materials | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2009-09-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090220615-A1 | Main Chain Acid-Degradable Polymers for the Delivery of Bioactive Materials | CTSA, GAA, CTSB | CYP2C19 4130/4885MEN1 924/4885GLA 59/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.